Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 20/20 | 0.56 |
| ▸ | KDM4A | O75164 | 13/20 | 0.56 |
| ▸ | KDM5A | P29375 | 8/20 | 0.53 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.53 |
| ▸ | KDM5C | P41229 | 1/20 | 0.50 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.50 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.46 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13811063 | 0.93 | KDM4C (0.53) | KDM4CKDM4AKDM5APHF8KDM5C | |
| SCHEMBL11774570 | 0.86 | TSHR (0.60) | KDM4CKDM4AKDM5APHF8KDM5C | |
| SCHEMBL14075852 | 0.85 | KDM4C (0.50) | KDM4CKDM4AKDM5APHF8KDM5C | |
| SCHEMBL26495567 | 0.82 | GPR84 (0.67) | KDM4CKDM4AKDM5APHF8KDM5C | |
| SCHEMBL26495628 | 0.82 | GPR84 (0.67) | KDM4CKDM4AKDM5APHF8KDM5C | |
| SCHEMBL26495563 | 0.82 | GPR84 (0.60) | KDM4CKDM4AKDM5APHF8KDM5C | |
| SCHEMBL26495622 | 0.82 | GPR84 (0.54) | KDM4CKDM4AKDM5APHF8KDM5C | |
| SCHEMBL12051225 | 0.82 | GPR84 (0.54) | KDM4CKDM4AKDM5APHF8KDM5C | |
| SCHEMBL14569694 | 0.82 | GPR84 (0.60) | KDM4CKDM4AKDM5APHF8KDM5C | |
| SCHEMBL26495495 | 0.82 | GPR84 (0.60) | KDM4CKDM4AKDM5APHF8KDM5C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12029790-B2 | Biomimetic nanomaterials and uses thereof | OHIO STATE INNOVATION FOUNDATION (US) | 2024-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12029790-B2 | Biomimetic nanomaterials and uses thereof | MTREX, HAVCR2, TSG101 | KDM4C 4411/4885KDM4A 4565/4885KDM5A 4784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.